KNSA Earnings Kiniksa Pharmaceuticals International, Plc
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–23 of 23
| Q1 2026 | 2026-03-31 | 0.27 | 2026-04-28 | 10-Q |
| FY 2025 | 2025-12-31 | 0.75 | 2026-02-24 | 10-K |
| Q3 2025 | 2025-09-30 | 0.57 | 2025-10-28 | 10-Q |
| Q2 2025 | 2025-06-30 | 0.34 | 2025-07-29 | 10-Q |
| Q1 2026 | 2025-03-31 | 0.11 | 2026-04-28 | 10-Q |
| FY 2025 | 2024-12-31 | -0.60 | 2026-02-24 | 10-K |
| Q3 2025 | 2024-09-30 | -0.48 | 2025-10-28 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.31 | 2025-07-29 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.25 | 2025-04-29 | 10-Q |
| FY 2025 | 2023-12-31 | 0.20 | 2026-02-24 | 10-K |
| Q3 2024 | 2023-09-30 | -0.16 | 2024-10-29 | 10-Q |
| Q2 2024 | 2023-06-30 | 0.04 | 2024-07-25 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.18 | 2024-04-25 | 10-Q |
| FY 2024 | 2022-12-31 | 2.60 | 2025-02-25 | 10-K |
| Q3 2023 | 2022-09-30 | 2.55 | 2023-11-02 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.65 | 2023-08-01 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.36 | 2023-05-04 | 10-Q |
| FY 2023 | 2021-12-31 | -2.30 | 2024-02-28 | 10-K |
| Q3 2022 | 2021-09-30 | -1.78 | 2022-11-03 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.33 | 2022-08-04 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.72 | 2022-05-05 | 10-Q |
| FY 2022 | 2020-12-31 | -2.61 | 2023-03-02 | 10-K |
| FY 2021 | 2019-12-31 | -2.99 | 2022-02-24 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.